We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+13.38%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.58%
5 Year Est. Return
+121.05%
10 Year Est. Return
+327.07%
AUM
$744M
AUM Growth
+$5.93M
Cap. Flow
-$65.5M
Cap. Flow %
-8.8%
Top 10 Hldgs %
39.66%
Holding
303
New
62
Increased
47
Reduced
54
Closed
61

Top Buys

Rank Stock Value
1
FMX icon
Fomento Económico Mexicano
FMX
+$10.5M
2
CRC icon
California Resources
CRC
+$10.5M
3
UNVR
Univar Solutions Inc.
UNVR
+$7.2M
4
SPH icon
Suburban Propane Partners
SPH
+$4.98M
5
WRK
WestRock Company
WRK
+$3.9M

Top Sells

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$17M
2
PHIC
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
+$13.7M
3
LGV
Longview Acquisition Corp. II
LGV
+$13.3M
4
EPWR
Empowerment & Inclusion Capital I Corp.
EPWR
+$11.8M
5
GIIX
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Financials 18.7%
2 Consumer Discretionary 12.92%
3 Healthcare 10.89%
4 Industrials 10.63%
5 Consumer Staples 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSX
226
DELISTED
VanEck Russia ETF
RSX
$56.5K 0.01%
10,000
– –
ROVR
227
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$56.1K 0.01%
15,286
– –
PLSE icon
228
Pulse Biosciences
PLSE
$3.17B
$55.2K 0.01%
19,939
– –
ADV icon
229
Advantage Solutions
ADV
$387M
$52K 0.01%
1,000
-2,200
-69% -$138K
LUCD icon
230
Lucid Diagnostics
LUCD
$183M
$50K 0.01%
+36,799
New +$66.2K
ASPU
231
DELISTED
ASPEN GROUP, INC.
ASPU
$46.5K 0.01%
+150,000
New +$54.4K
SOFI icon
232
PUT
SoFi Technologies
SOFI
$23.2B
$46.1K 0.01%
+10,000
New +$49.6K
FUBO icon
233
FuboTV Inc
FUBO
$293M
$17.4K ﹤0.01%
+833
New +$30.5K
CPAAW
234
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$16.1K ﹤0.01%
108,328
-4,716
-4% -$685
LAB icon
235
Standard BioTools
LAB
$309M
$16K ﹤0.01%
13,672
– –
DAVE icon
236
Dave Inc
DAVE
$3.95B
$13.6K ﹤0.01%
1,460
– –
SVIIR
237
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$10.6K ﹤0.01%
+62,512
New +$10.1K
PAVMZ
238
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$10.3K ﹤0.01%
45,775
-31,250
-41% -$12.9K
ABLLW
239
DELISTED
Abacus Life Warrant
ABLLW
$8.75K ﹤0.01%
50,000
– –
HBI
240
DELISTED
Hanesbrands
HBI
$6.36K ﹤0.01%
+1,000
New +$6.87K
SVIIW
241
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$5.94K ﹤0.01%
+31,256
New +$6.13K
IMDX
242
Insight Molecular Diagnostics
IMDX
$145M
$3.37K ﹤0.01%
525
– –
AMPX.WS icon
243
Amprius Technologies Warrants
AMPX.WS
$569M
– –
-14,250
Closed -$5K
AOS icon
244
PUT
A.O. Smith
AOS
$8.65B
– –
-7,000
Closed -$340K
C icon
245
Citigroup
C
$228B
– –
-5,217
Closed -$217K
CNA icon
246
CNA Financial
CNA
$13.8B
– –
-22,770
Closed -$840K
CNM icon
247
Core & Main
CNM
$8.73B
– –
-15,000
Closed -$341K
CPS icon
248
CALL
Cooper-Standard Automotive
CPS
$487M
– –
-20,000
Closed -$117K
DNLI icon
249
Denali Therapeutics
DNLI
$3.95B
– –
-9,500
Closed -$292K
DXC icon
250
CALL
DXC Technology
DXC
$1.73B
– –
-12,500
Closed -$306K
8 9
10
11 12

Similar funds

RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
OA
Oak Associates Akron, Ohio $1.49B AUM 34.25% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

Levin Capital Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Levin Capital Strategies held 303 positions worth $744M, up 0.8% from $738M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Levin Capital Strategies withdrew a net $65.5M in Q4 2022, closing 61 positions and reducing 54 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Levin Capital Strategies opened a new position in Fomento Económico Mexicano worth $11.1M.

  • Levin Capital Strategies's largest Q4 2022 buy was Fomento Económico Mexicano: 142,318 shares worth $11.1M.
  • Levin Capital Strategies added most to California Resources in Q4 2022, an estimated $10.5M increase.
  • Levin Capital Strategies's biggest Q4 2022 reduction was Apple, cutting an estimated $7.27M.
  • Levin Capital Strategies fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $17M.
  • Levin Capital Strategies's ten largest holdings make up 40% of its $744M portfolio in Q4 2022.
  • Levin Capital Strategies opened 62 new positions and closed 61 in Q4 2022.
  • Levin Capital Strategies's portfolio value rose 0.8% quarter-over-quarter to $744M.

Based on Levin Capital Strategies's 13F filing for Q4 2022, filed 13 Feb 2023.